Federated Hermes International Leaders Fund Class R (FGFRX) is a Foreign Large Blend fund with $1.85 Billion in assets. The fund allocates 26.52% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is AstraZeneca PLC at 3.70% of total assets. This is followed by Siemens AG (3.08%) and Novo Nordisk A/S (3.40%).
| Name | Weight | Owned | Change |
|---|---|---|---|
| AstraZeneca PLC | 3.70% | - | - |
| Siemens AG | 3.08% | - | - |
| Novo Nordisk A/S | 3.40% | - | - |
| ASML Holding NV | 3.25% | - | - |
| Keyence Corp | 1.95% | - | - |
| National Grid PLC | 2.85% | - | - |
| Sanofi | 2.06% | - | - |
| Sony Group Corp | 2.13% | - | - |
| Deutsche Telekom AG | 2.32% | - | - |
| HSBC Holdings PLC | 1.78% | - | - |
| Federated Hermes Government Obligations Fund | 4.17% | - | - |
| Kerry Group PLC | 2.02% | - | - |
| UBS Group AG | 1.91% | - | - |
| Hitachi Ltd | 2.03% | - | - |
| DSM-Firmenich AG | 1.86% | - | - |
| Melrose Industries PLC | 2.15% | - | - |
| Banco Santander SA | 1.84% | - | - |
| Mitsubishi Estate Co Ltd | 1.72% | - | - |
| UniCredit SpA | 1.67% | - | - |